GO:2000408 negative regulation of T cell extravasation: Immune Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000408 describes any process that stops, prevents, or reduces the frequency, rate, or extent of T cell extravasation, a critical step in immune cell trafficking.
• T cell extravasation is a multi-step cascade involving chemotaxis, adhesion, and transmigration, and its negative regulation is essential to prevent excessive tissue damage.
• Key molecular players include integrins (e.g., α4β7, LFA-1), chemokine receptors, and glycans that modulate adhesion and migration.
• Dysregulation of T cell extravasation contributes to inflammatory diseases, cancer, and ischemia-reperfusion injury.
• Studying this process requires advanced models such as knockout mice, point-mutation knock-ins, and CRISPR screening to dissect gene function.
• EDITGENE provides comprehensive CRISPR services to interrogate genes involved in negative regulation of T cell extravasation for therapeutic development.
Description
T cell extravasation is the process by which circulating T lymphocytes exit the bloodstream and enter tissues, a fundamental event in immune surveillance and inflammation. This process is tightly controlled to avoid inappropriate immune cell infiltration that can lead to tissue damage. The Gene Ontology term GO:2000408, negative regulation of T cell extravasation, encompasses any mechanism that inhibits or reduces the frequency, rate, or extent of this migration. Understanding these regulatory mechanisms is crucial for developing therapies against inflammatory diseases, autoimmune disorders, and cancer. Recent studies have highlighted the role of glycans, integrins, and chemokines in modulating T cell extravasation. For example, the interaction of GATA-3 and T-bet transcription factors regulates the expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes, influencing their migratory capacity. Additionally, the small GTPase Rap1 mediates CD31-induced integrin adhesion, a key step in T cell arrest on endothelium. These findings underscore the complexity of negative regulation and the need for precise experimental models to study it.
negative regulation of T cell extravasation At A Glance
| GO ID | GO:2000408 |
|---|---|
| GO term | negative regulation of T cell extravasation |
| Ontology | biological_process |
| Synonym | negative regulation of T-cell extravasation; negative regulation of T lymphocyte extravasation; negative regulation of T-lymphocyte extravasation |
| Major function | Inhibition or reduction of T cell migration from blood into tissues |
| Related processes | T cell adhesion, chemotaxis, transmigration, immune surveillance |
| Key molecules | Integrins, chemokine receptors, glycans, GTPases, transcription factors |
| Disease relevance | Inflammation, autoimmunity, cancer, ischemia-reperfusion injury |
What Is GO:2000408?
GO:2000408, negative regulation of T cell extravasation, is defined as any biological process that stops, prevents, or reduces the frequency, rate, or extent of T cell extravasation. This includes molecular signals that inhibit T cell adhesion to endothelial cells, block chemokine-mediated migration, or promote retention of T cells in the bloodstream. The term is a biological process and is synonymous with negative regulation of T-cell extravasation, T lymphocyte extravasation, and T-lymphocyte extravasation.
Why Is negative regulation of T cell extravasation Important in Cell Biology?
Negative regulation of T cell extravasation is critical for maintaining immune homeostasis and preventing excessive tissue infiltration that can cause inflammatory damage. Dysregulation of this process is implicated in a range of pathologies, from autoimmune diseases to cancer and ischemia-reperfusion injury. Understanding the molecular mechanisms that restrain T cell migration offers opportunities for therapeutic intervention, such as blocking unwanted T cell entry into tissues during chronic inflammation or enhancing it for tumor immunotherapy. Moreover, the interplay between glycans, integrins, and chemokines in this regulation highlights potential targets for drug development.
• Prevents excessive T cell infiltration and tissue damage in inflammatory conditions.
• Modulates immune responses in autoimmune diseases by controlling T cell access to target organs.
• Influences cancer progression by regulating T cell entry into tumors.
• Plays a role in ischemia-reperfusion injury, where double-negative T cells attenuate lung injury.
• Involves glycans and their binding partners, offering glyco-immune therapeutic targets.
• Requires tight regulation of integrin affinity and avidity for proper T cell arrest.
• Transcription factors like GATA-3 and T-bet control homing receptor expression, affecting extravasation.
• Bacterial components can stimulate T cell adhesion to endothelium, highlighting microbial influence.
• Allergen-induced airway inflammation involves eosinophilic cytokines, but T cell extravasation is also a key component.
• Understanding negative regulation can guide development of anti-inflammatory drugs.
What Happens During negative regulation of T cell extravasation?
Inhibition of T cell adhesion to endothelium
In simple terms: Stopping T cells from sticking to blood vessel walls.
Negative regulation of T cell extravasation often begins with mechanisms that reduce the ability of T cells to adhere to endothelial cells. This can occur through modulation of integrin affinity or avidity. For instance, the small GTPase Rap1 mediates CD31-induced integrin adhesion, and its negative regulation can prevent T cell arrest. Additionally, glycans and their binding partners can interfere with selectin-mediated rolling and integrin activation, thereby inhibiting adhesion. Bacterial components such as those from Bacteroides vulgatus can stimulate T cell adhesion, suggesting that negative regulation may counteract microbial stimuli.
Blockade of chemokine-mediated chemotaxis
In simple terms: Preventing T cells from following chemical signals into tissues.
Chemokines direct T cell migration, and negative regulation can involve desensitization or blockade of chemokine receptors. In a hypoxic environment, monocytes and dendritic cells show altered chemotaxis, and similar mechanisms may apply to T cells. The interaction of GATA-3 and T-bet transcription factors regulates the expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes, which affects their chemotactic response. Thus, transcriptional control of homing receptors is a key point of negative regulation.
Regulation of transmigration through endothelial layer
In simple terms: Controlling the final step where T cells squeeze through blood vessel walls.
After adhesion, T cells must transmigrate through the endothelial layer. Negative regulation can inhibit this step by altering junctional molecules or cytoskeletal dynamics. Double-negative αβ T cells have been shown to attenuate lung ischemia-reperfusion injury, potentially by modulating transmigration of conventional T cells. The glycocalyx and glycan-binding proteins also play a role in regulating transmigration.
Transcriptional and post-transcriptional control
In simple terms: Turning genes on or off to reduce T cell migration.
Long-term negative regulation involves changes in gene expression. Transcription factors such as GATA-3 and T-bet reciprocally regulate homing receptor expression, influencing Th1/Th2 migration. Additionally, microRNAs and other non-coding RNAs can post-transcriptionally silence genes required for extravasation. This layer of regulation ensures that T cells remain in circulation when appropriate.
Role of glycans in negative regulation
In simple terms: Sugar molecules on cell surfaces can block T cell migration.
Glycans and their binding partners are emerging as key regulators of immunity, including T cell extravasation. Sialyl Lewis X, a glycan ligand for selectins, is regulated by GATA-3/T-bet and affects T cell homing. Alterations in glycosylation can therefore inhibit or promote extravasation. This highlights the potential of glyco-immune interventions to modulate T cell trafficking.
Key Genes Involved in GO:2000408 negative regulation of T cell extravasation
The following genes and proteins are involved in the negative regulation of T cell extravasation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Rap1 | Small GTPase mediating integrin adhesion | Target for modulating T cell arrest |
| CD31 | Endothelial adhesion molecule that activates Rap1 | Regulates integrin affinity |
| GATA-3 | Transcription factor regulating Th2 homing receptors | Controls sialyl Lewis X expression |
| T-bet | Transcription factor regulating Th1 homing receptors | Antagonizes GATA-3 |
| α4β7 integrin | Mediates T cell adhesion to MAdCAM-1 | Associated with leukemic evolution |
| LFA-1 | Integrin mediating firm adhesion | Target for negative regulation |
| Sialyl Lewis X | Glycan ligand for selectins | Modulated by GATA-3/T-bet |
| Chemokine receptors | Mediate chemotaxis | Desensitization inhibits extravasation |
| Bacteroides vulgatus components | Stimulate T cell adhesion | Microbial influence on extravasation |
| Eosinophilic cytokines | Promote airway inflammation | Indirectly affect T cell recruitment |
| Double-negative αβ T cells | Attenuate ischemia-reperfusion injury | May negatively regulate conventional T cell extravasation |
| Glycan-binding proteins | Modulate immune cell migration | Potential therapeutic targets |
| CD3+CD4-CD8- T cells | Regulatory T cell subset | Involved in lung injury |
| Integrins | Adhesion molecules | Key players in extravasation |
| Selectins | Mediate rolling | Glycan ligands regulate |
| Chemokines | Chemoattractants | Regulate migration |
| GTPases | Signal transduction | Rap1 is a key example |
How Is negative regulation of T cell extravasation Regulated?
Negative regulation of T cell extravasation is controlled at multiple levels. Transcriptional regulation by GATA-3 and T-bet determines the expression of homing receptors such as sialyl Lewis X, which in turn affects T cell migration. Post-translational modifications, including glycosylation, modulate selectin binding and integrin function. Signaling through small GTPases like Rap1 is critical for integrin activation, and its negative regulation can prevent adhesion. Additionally, chemokine receptor desensitization and internalization reduce chemotaxis. The presence of bacterial components can stimulate adhesion, suggesting that negative regulation may counteract microbial signals. Overall, a balance between positive and negative signals ensures proper T cell trafficking.
negative regulation of T cell extravasation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GATA-3 | Allergic asthma, Th2-mediated inflammation | Knockout mice, point mutation |
| T-bet | Autoimmune diseases, Th1 responses | Knock-in reporter mice |
| α4β7 integrin | T-cell lymphoblastic lymphoma | Overexpression in murine models |
| Rap1 | Inflammatory diseases, integrin adhesion | Knockout and point mutation |
| Double-negative αβ T cells | Lung ischemia-reperfusion injury | Adoptive transfer in mice |
Inflammatory and autoimmune diseases
Excessive T cell extravasation contributes to chronic inflammation and autoimmune tissue damage. Negative regulation is essential to limit T cell entry into target organs. For example, the balance of GATA-3 and T-bet influences Th1/Th2 migration and is implicated in allergic asthma and autoimmune conditions. Glycan-mediated regulation also plays a role in inflammatory diseases.
Cancer
T cell extravasation into tumors is required for effective immunotherapy, but tumors often suppress this process. Negative regulation can be hijacked by tumors to exclude T cells. α4β7 integrin expression is associated with leukemic evolution of T-cell lymphoblastic lymphomas, suggesting a role in cancer progression. Modulating negative regulation could enhance T cell entry into tumors.
Ischemia-reperfusion injury
In lung ischemia-reperfusion injury, double-negative αβ T cells attenuate injury, potentially by negatively regulating conventional T cell extravasation. This highlights the therapeutic potential of targeting negative regulation to reduce tissue damage.
Allergic airway inflammation
Allergen-induced airway inflammation involves eosinophilic cytokines and T cell recruitment. Negative regulation of T cell extravasation could reduce airway inflammation in asthma.
From negative regulation of T cell extravasation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate T cell extravasation? | Knockout mouse (gene X-/-) |
| Does a specific point mutation in gene Y affect its function? | Point-mutation knock-in mouse |
| Can we visualize gene Z expression during extravasation? | Tagged knock-in reporter mouse |
| Does overexpression of gene W inhibit T cell migration? | Transgenic overexpression mouse |
| Which genes are essential for negative regulation? | CRISPR library screening in T cells |
| How does glycosylation affect extravasation? | Glyco-engineered mouse models |
How to Study the negative regulation of T cell extravasation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Intravital microscopy | T cell migration in live tissues | Visualizing extravasation dynamics |
| Flow cytometry | T cell counts in tissues | Quantifying migration after adoptive transfer |
| Adhesion assay | T cell binding to endothelial cells | Testing integrin function |
| Transmigration assay | T cell passage through endothelial layer | Studying negative regulators |
| RNA-seq | Gene expression changes | Identifying transcriptional regulators |
| Phosphoproteomics | Signaling pathway activation | Mapping integrin signaling |
| CRISPR screen | Gene function on a genome-wide scale | Discovering novel regulators |
In vivo migration assays
To study negative regulation of T cell extravasation, researchers use adoptive transfer of labeled T cells followed by intravital microscopy or flow cytometry to quantify migration into tissues. These assays can be combined with knockout or transgenic models to assess gene function.
In vitro adhesion and transmigration assays
Endothelial cell monolayers and chemokine gradients are used to measure T cell adhesion and transmigration in vitro. These assays allow precise manipulation of signaling pathways and can be adapted for high-throughput screening.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can identify genes and proteins differentially expressed during negative regulation. For example, GATA-3 and T-bet target genes have been identified by transcriptomics. Phosphoproteomics can reveal signaling changes in integrin pathways.
CRISPR screening
Genome-wide CRISPR knockout or activation screens in T cells can uncover novel regulators of extravasation. These screens are powerful for identifying genes that negatively regulate migration when lost or overexpressed.
How CRISPR Can Be Used to Study GO:2000408 negative regulation of T cell extravasation
Knockout
CRISPR knockout of candidate genes in T cells or mouse models can determine whether a gene is required for negative regulation of extravasation. For example, knocking out Rap1 would test its role in integrin adhesion. Knockout of GATA-3 or T-bet would reveal their impact on homing receptor expression.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to dissect specific phosphorylation sites. For instance, mutating Rap1 GTPase activity would clarify its role in integrin activation. Point mutations in GATA-3 DNA-binding domain could affect homing receptor expression.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags allows visualization and tracking of proteins involved in negative regulation. Tagging endogenous Rap1 or integrins would enable live-cell imaging of their dynamics during extravasation.
Overexpression
Overexpression of candidate negative regulators can test whether increased levels inhibit T cell extravasation. For example, overexpressing a glycan-modifying enzyme could alter selectin binding and reduce migration. Overexpression of double-negative T cell receptors might attenuate injury.
How EDITGENE Supports negative regulation of T cell extravasation Research
Researchers studying negative regulation of T cell extravasation-related genes often need to determine whether a candidate gene is causally involved in inhibiting T cell migration. This requires precise genetic manipulation, which can be achieved through CRISPR-based models. EDITGENE provides a comprehensive suite of services to support such investigations, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of T cell extravasation research.
Frequently Asked Questions About negative regulation of T cell extravasation
What is GO:2000408?
GO:2000408 is the Gene Ontology term for negative regulation of T cell extravasation, describing any process that stops, prevents, or reduces the frequency, rate, or extent of T cell migration from blood into tissues.
What genes are involved in negative regulation of T cell extravasation?
Key genes include Rap1, CD31, GATA-3, T-bet, and integrins such as α4β7 and LFA-1, as well as glycan-modifying enzymes.
How is T cell extravasation negatively regulated?
It is regulated at multiple levels, including inhibition of adhesion, blockade of chemotaxis, transcriptional control of homing receptors, and glycan-mediated interference.
Why is negative regulation of T cell extravasation important?
It prevents excessive T cell infiltration that can cause tissue damage in inflammation and autoimmunity, and its dysregulation is linked to cancer and ischemia-reperfusion injury.
What diseases are associated with defective negative regulation of T cell extravasation?
Inflammatory diseases, autoimmune disorders, cancer, and ischemia-reperfusion injury are associated with altered negative regulation.
What experimental models are used to study negative regulation of T cell extravasation?
Models include knockout mice, point-mutation knock-ins, reporter knock-ins, overexpression mice, and CRISPR screens in T cells.
How can CRISPR be used to study negative regulation of T cell extravasation?
CRISPR can knockout, mutate, knock-in, or overexpress candidate genes to test their effects on T cell migration in vitro and in vivo.
What is the role of glycans in T cell extravasation?
Glycans such as sialyl Lewis X mediate selectin binding and are regulated by transcription factors like GATA-3 and T-bet, affecting T cell homing.
What is the role of Rap1 in T cell extravasation?
Rap1 is a small GTPase that mediates CD31-induced integrin adhesion, a key step in T cell arrest on endothelium; its negative regulation prevents adhesion.
How does hypoxia affect T cell extravasation?
Hypoxia alters chemotaxis and migration of monocytes and dendritic cells, and similar mechanisms may influence T cells in inflamed tissues.
Conclusion
Negative regulation of T cell extravasation (GO:2000408) is a vital biological process that restrains T cell migration into tissues, preventing excessive inflammation and tissue damage. Its dysregulation contributes to a variety of diseases, including autoimmunity, cancer, and ischemia-reperfusion injury. Understanding the molecular players, such as Rap1, GATA-3, T-bet, and glycans, provides opportunities for therapeutic intervention. Advanced CRISPR models and screening approaches are essential to dissect these mechanisms. EDITGENE offers comprehensive services to support research in this field, from gene knockout to overexpression and bioinformatics.
References
- 1. Hsu J et al.. 2021. CD3(+)CD4(-)CD8(-) Double-negative αβ T cells attenuate lung ischemia-reperfusion injury.. J Thorac Cardiovasc Surg 161(1):e81-e90 PMID: 31864698
- 2. Johnson JL et al.. 2013. The regulatory power of glycans and their binding partners in immunity.. Trends Immunol 34(6):290-8 PMID: 23485517
- 3. Bosco MC et al.. 2008. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.. Immunobiology 213(9-10):733-49 PMID: 18926289
- 4. Dolcetti R et al.. 1997. Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.. Am J Pathol 150(5):1595-605 PMID: 9137086
- 5. Chen GY et al.. 2006. Interaction of GATA-3/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes.. Proc Natl Acad Sci U S A 103(45):16894-9 PMID: 17075044
- 6. Meisel-Mikołajczyk F et al.. 1993. Human T cell adhesion to endothelium stimulated by membrane components extracted from strains of Bacteroides vulgatus (member of B. fragilis group).. Arch Immunol Ther Exp (Warsz) 41(2):129-31 PMID: 8239916
- 7. Gauvreau GM et al.. 1999. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation.. Am J Respir Crit Care Med 160(2):640-7 PMID: 10430741
- 8. Reedquist KA et al.. 2000. The small GTPase, Rap1, mediates CD31-induced integrin adhesion.. J Cell Biol 148(6):1151-8 PMID: 10725328
